Published in FEBS Lett on December 01, 1973
Isolation and characterization of a human serum cholesteryl ester transfer protein. Proc Natl Acad Sci U S A (1978) 1.30
Genetic studies of human apolipoproteins. IX. Apolipoprotein D polymorphism and its relation to serum lipoprotein lipid levels. Am J Hum Genet (1989) 1.12
Radioimmunoassay of human plasma lecithin-cholesterol acyltransferase. J Clin Invest (1981) 1.09
Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Proc Natl Acad Sci U S A (2001) 1.06
Hepatitis B antigen: antigenic sites related to human serum proteins revealed by affinity chromatography. Proc Natl Acad Sci U S A (1974) 0.94
Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. Neurobiol Aging (2014) 0.93
Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging. Aging (Albany NY) (2009) 0.92
Apolipoprotein D: an overview of its role in aging and age-related diseases. Cell Cycle (2010) 0.88
New protein in human blood plasma, rich in proline, with lipid-binding properties. Proc Natl Acad Sci U S A (1976) 0.86
Identification of differentially expressed genes in the developing antler of red deer Cervus elaphus. Mol Genet Genomics (2006) 0.85
Expression and prognostic significance of apolipoprotein D in breast cancer. Am J Pathol (1994) 0.83
Apolipoprotein D synthesis progressively increases in frontal cortex during human lifespan. Age (Dordr) (2010) 0.80
Apolipoprotein D Transgenic Mice Develop Hepatic Steatosis through Activation of PPARγ and Fatty Acid Uptake. PLoS One (2015) 0.77
Cerebral Apolipoprotein-D Is Hypoglycosylated Compared to Peripheral Tissues and Is Variably Expressed in Mouse and Human Brain Regions. PLoS One (2016) 0.75
Immunogenetic polymorphism of lipoproteins in swine: genetic, immunological and physiochemical characterization of the two allotypes Lpr1 and Lpr2. Genetics (1986) 0.75
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation (2000) 2.47
Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation (1993) 2.04
A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest (1969) 1.93
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation (1990) 1.89
Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med (1993) 1.82
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest (1985) 1.79
Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Biochim Biophys Acta (1972) 1.73
Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med (1982) 1.67
Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis (1982) 1.45
Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med (1996) 1.43
Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron (1993) 1.42
Aortic valve thickening associated with power training: is it pressure overload? Am J Cardiol (1998) 1.40
Degradative effect of phenol on endotoxin and lipopolysaccharide preparations from Serratia marcescens. J Bacteriol (1974) 1.39
Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial. Circulation (1995) 1.38
Lipoprotein metabolism and renal failure. Am J Kidney Dis (1993) 1.37
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant (1997) 1.33
Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. N Engl J Med (1978) 1.23
Apoliproproteins and lipoproteins. Atherosclerosis (1971) 1.17
Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J Lipid Res (1989) 1.17
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrol Dial Transplant (1994) 1.17
Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. Clin Chem (1976) 1.15
Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation (1994) 1.14
Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion. Eur J Clin Invest (1981) 1.14
Studies of the composition and structure of plasma lipoproteins. Isolation, composition, and immunochemical characterization of low density lipoprotein subfractions of human plasma. Biochemistry (1970) 1.12
Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens 08. Biochemistry (1973) 1.11
Anabolic steroid-induced hepatotoxicity: is it overstated? Clin J Sport Med (1999) 1.10
Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest (1990) 1.08
Determination of human apolipoprotein E by electroimmunoassay. Biochim Biophys Acta (1976) 1.06
Studies of the composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occurring in the high density lipoproteins of human plasma. Biochemistry (1972) 1.05
Structure and functional properties of lipoprotein lipase. Biochim Biophys Acta (1992) 1.05
A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. J Clin Invest (1970) 1.04
The differential diagnosis of neonatal hepatitis and biliary atresia. J Pediatr Surg (1974) 1.04
Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res (1983) 1.03
Studies on the characterization of lipopolysaccharides from two strains of Serratia marcescens. Ann N Y Acad Sci (1966) 1.03
Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. Nephron (1991) 1.02
Quantitative determination of human apolipoprotein C-III by electroimmunoassay. Biochim Biophys Acta (1980) 1.02
Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: clinical aspects. Clin Cardiol (1999) 1.02
Studies of the composition and structure of serum lipoproteins. Separation and characterization of phospholipid-protein residues obtained by partial delipidization of very low density lipoproteins of human serum. Biochemistry (1966) 1.02
Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects. J Clin Invest (1984) 1.00
Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma. Biochemistry (1978) 1.00
Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens Bizio. Biochemistry (1973) 0.99
Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes. Biochim Biophys Acta (1987) 0.98
Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. Clin Chem (1978) 0.98
Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma. Biochemistry (1976) 0.97
Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins. J Biol Chem (1991) 0.97
Growth hormone in the regulation of hyperlipidemia. Metabolism (1982) 0.96
Purification and molecular cloning of human apolipoprotein F. Biochem Biophys Res Commun (1994) 0.95
Effects of medium chain length triglyceride (MCT) on serum lipids and lipoproteins in familial hyperchylomicronemia (dietary fat-induced lipemia) and dietary carbohydrate-accentuated lipemia. J Lab Clin Med (1965) 0.95
Intra-ocular pressure changes during maximal isometric contraction: does this reflect intra-cranial pressure or retinal venous pressure? Neurol Res (1999) 0.94
Quantitative determination of human apolipoprotein D by electroimmunoassay and radial immunodiffusion. Biochim Biophys Acta (1977) 0.93
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J Am Soc Nephrol (1998) 0.92
David Rubinstein Memorial Lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins. Can J Biochem (1981) 0.92
Left ventricular size and function in elite bodybuilders using anabolic steroids. Clin J Sport Med (1997) 0.92
Kinetics of bovine milk lipoprotein lipase and the mechanism of enzyme activation by apolipoprotein C-II. Biochemistry (1983) 0.91
Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate. Arterioscler Thromb Vasc Biol (1997) 0.91
Effects of saturated, monounsaturated, and omega-6 polyunsaturated fatty acids on plasma lipids, lipoproteins, and apoproteins in humans. Am J Clin Nutr (1983) 0.91
Physiocochemical properties of low-density lipoproteins of normal human plasma. Evidence for the occurrence of lipoprotein B in associated and free forms. Biochem J (1974) 0.91
Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Atherosclerosis (1981) 0.91
Plasma lipids and apolipoproteins in a 13-year-old boy with diabetic ketoacidosis and extreme hyperlipidemia. Am J Med Sci (1986) 0.90
Production of apolipoproteins E and A-I by rat hepatocytes in primary culture. Biochim Biophys Acta (1980) 0.90
Binding and degradation of human high-density lipoproteins by human hepatoma cell line HepG2. Biochim Biophys Acta (1985) 0.90
Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay. Clin Chem (1987) 0.89
Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films. Eur J Biochem (1984) 0.89
Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. Neuroreport (1995) 0.89
Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology (1995) 0.89
Serum lipids and apolipoproteins in women with breast masses. Breast Cancer Res Treat (1995) 0.89
Increased production of apolipoprotein B and its lipoproteins by oleic acid in Caco-2 cells. J Lipid Res (1990) 0.89
The comparative kinetics of soluble and heparin-Sepharose-immobilized bovine lipoprotein lipase. Arch Biochem Biophys (1983) 0.89
Identification of lipoprotein families in a variant of human plasma apolipoprotein A deficiency. Scand J Clin Lab Invest (1979) 0.88
Interactions of low density lipoprotein2 and other apolipoprotein B-containing lipoproteins with lipoprotein(a). J Biol Chem (1988) 0.88
Differential activation of lipoprotein lipase from human post-heparin plasma, milk and adipose tissue by polypeptides of human serum Apolipoprotein C. FEBS Lett (1971) 0.88
Pressure-overload-induced sliding hiatal hernia in power athletes. J Clin Gastroenterol (1999) 0.88
Isolation and characterization of human chyle chylomicrons and lipoproteins. Ann N Y Acad Sci (1968) 0.88
Catabolism of human low density lipoproteins by human hepatoma cell line HepG2. Biochim Biophys Acta (1984) 0.88
Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk. J Cardiovasc Risk (1999) 0.87
Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels. Atherosclerosis (1989) 0.87
Determination of serum lipoprotein-X for the early differentiation between neonatal hepatitis and biliary atresia. J Surg Res (1975) 0.87
Lipoprotein(a) binding to other apolipoprotein B containing lipoproteins. Biochemistry (1990) 0.86
The compositional abnormalities of lipoproteins in diabetic renal failure. Nephrol Dial Transplant (1998) 0.86
Middle cerebral artery blood flow velocity in elite power athletes during maximal weight-lifting. Neurol Res (2000) 0.86
Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int (1987) 0.85
Glyceraldehyde-3-phosphate dehydrogenase from human erythrocyte membranes. Kinetic mechanism and competitive substrate inhibition by glyceraldehyde 3-phosphate. Arch Biochem Biophys (1980) 0.85
Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays. Clin Chem (1981) 0.85
Plasma lipid and apolipoprotein profiles of women with two types of peripheral arterial disease. Atherosclerosis (1984) 0.85
Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance. Am J Obstet Gynecol (1992) 0.85
Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency. Atherosclerosis (1982) 0.85
Distribution of lipids and apolipoproteins in human plasma by vertical spin ultracentrifugation. Arch Biochem Biophys (1986) 0.84